Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation

• Yoshihide Ueda ,

  * E-mail: yueda@kuhp.kyoto-u.ac.jp

  Affiliation Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Toshimi Kaido,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Yasuhiro Ogura,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Kohei Ogawa,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Atsushi Yoshizawa,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Koichiro Hata,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Yasuhiro Fujimoto,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Aya Miyagawa-Hayashino,

  Affiliation Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Hironori Haga,

  Affiliation Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Hiroyuki Marusawa,

  Affiliation Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Satoshi Teramukai,

  Affiliation Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, Japan

  ⨯
• Shinji Uemoto,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Tsutomu Chiba

  Affiliation Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯